Valuation: RaySearch Laboratories AB

Market Cap 6.17B 651M 563M 526M 482M 907M 61.93B 921M 2.42B 31.04B 2.44B 2.39B 103B P/E 2026 *
23.1x
P/E 2027 * 18.9x
Enterprise Value 6.34B 669M 578M 540M 495M 932M 63.63B 947M 2.49B 31.89B 2.51B 2.46B 105B EV / Sales 2026 *
4.54x
EV / Sales 2027 * 3.8x
Free-Float
80.09%
Yield 2026 *
2.22%
Yield 2027 * 2.65%
1 day+11.87%
1 month-10.96%
3 months-23.45%
6 months-18.04%
Current year-20.80%
1 month 16.85
Extreme 16.85
24
Current year 16.85
Extreme 16.85
24.62
1 year 16.85
Extreme 16.85
30.75
3 years 8
Extreme 8
37.36
5 years 4.04
Extreme 4.039
37.36
10 years 4.04
Extreme 4.039
37.36
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
+11.87%-.--% - - 651M
+5.82%+13.10%-17.62%+17.10% 37.44B
-1.07%+8.55%-44.95%+147.90% 12.99B
+1.06%+0.07%-24.59%+63.05% 5.44B
+5.99%+14.23% - - 2.49B
+3.31%+2.50% - - 1.84B
+1.80%+4.07%+18.63%-43.60% 1.68B
+0.08%-2.57%-36.05% - 1.02B
+1.98%+6.68%+36.18%+120.48% 915M
-1.36%+1.68%-37.84%-46.77% 833M
Average +2.95%+5.27%-15.18%+43.02% 7.18B
Weighted average by Cap. +3.71%+10.10%-22.90%+48.95%

Financials

2026 *2027 *
Net sales 1.4B 147M 127M 119M 109M 205M 14.02B 209M 548M 7.03B 553M 541M 23.23B 1.63B 172M 149M 139M 127M 240M 16.37B 244M 640M 8.21B 646M 632M 27.13B
Net income 265M 27.96M 24.19M 22.59M 20.72M 38.97M 2.66B 39.59M 104M 1.33B 105M 103M 4.41B 320M 33.76M 29.21M 27.27M 25.02M 47.06M 3.21B 47.81M 126M 1.61B 127M 124M 5.32B
Net Debt 169M 17.83M 15.42M 14.4M 13.21M 24.85M 1.7B 25.25M 66.33M 851M 66.96M 65.5M 2.81B 25M 2.64M 2.28M 2.13M 1.95M 3.68M 251M 3.73M 9.81M 126M 9.91M 9.69M 416M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
179.90SEK
Average target price
310.00SEK
Spread / Average Target
+72.32%

Quarterly revenue - Rate of surprise